Latest on Human Papilloma Virus Vaccine for Cervical Cancer
/
RSS Feed
John Schiller
John Schiller, National Cancer Institute, Bethesda
The human papilloma virus vaccine, which is currently being tested in the prevention of cervical cancer, brings together both infectious disease and cancer. Delegates at the ICAAC conference heard an update on both the anti-cancer and the anti-wart activities of the two vaccines: one from Merck and the other from GlaxoSmithKline.
[audio:https://www.audiomedica.com/podcasting/icaac2005/john_schiller.mp3]
You may also like...
Malaria—Insecticide Research Promises To Beat Mosquito Resistance 2 Jan, 2012 
London School Of Hygiene And Tropical Medicine: New Director And The Global Health Agenda 21 Oct, 2010 - Vitamin A Supplements: No Help For Reducing Maternal Mortality 14 Aug, 2010
- Txt2Stop: Text Messaging Doubled Smoking Quit Rates 7 Jul, 2011
